Last reviewed · How we verify

Antifungal treatment

Hospices Civils de Lyon · FDA-approved active Small molecule

Antifungal treatment is a Antifungal agent (class varies by specific drug: azole, polyene, echinocandin, or other) Small molecule drug developed by Hospices Civils de Lyon. It is currently FDA-approved for Fungal infections (specific indication depends on formulation and active ingredient).

Antifungal treatments work by disrupting fungal cell wall or membrane integrity, or inhibiting essential fungal enzymes, thereby killing or stopping the growth of fungal organisms.

Antifungal treatments work by disrupting fungal cell wall or membrane integrity, or inhibiting essential fungal enzymes, thereby killing or stopping the growth of fungal organisms. Used for Fungal infections (specific indication depends on formulation and active ingredient).

At a glance

Generic nameAntifungal treatment
SponsorHospices Civils de Lyon
Drug classAntifungal agent (class varies by specific drug: azole, polyene, echinocandin, or other)
ModalitySmall molecule
Therapeutic areaInfectious Disease
PhaseFDA-approved

Mechanism of action

Antifungals target structures and processes unique to fungi, such as ergosterol in the fungal cell membrane (disrupted by azoles and polyenes) or fungal cell wall components like beta-glucans (targeted by echinocandins). By interfering with these critical fungal-specific structures, antifungals either cause cell lysis and death or prevent fungal replication, allowing the immune system to clear the infection.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Antifungal treatment

What is Antifungal treatment?

Antifungal treatment is a Antifungal agent (class varies by specific drug: azole, polyene, echinocandin, or other) drug developed by Hospices Civils de Lyon, indicated for Fungal infections (specific indication depends on formulation and active ingredient).

How does Antifungal treatment work?

Antifungal treatments work by disrupting fungal cell wall or membrane integrity, or inhibiting essential fungal enzymes, thereby killing or stopping the growth of fungal organisms.

What is Antifungal treatment used for?

Antifungal treatment is indicated for Fungal infections (specific indication depends on formulation and active ingredient).

Who makes Antifungal treatment?

Antifungal treatment is developed and marketed by Hospices Civils de Lyon (see full Hospices Civils de Lyon pipeline at /company/hospices-civils-de-lyon).

What drug class is Antifungal treatment in?

Antifungal treatment belongs to the Antifungal agent (class varies by specific drug: azole, polyene, echinocandin, or other) class. See all Antifungal agent (class varies by specific drug: azole, polyene, echinocandin, or other) drugs at /class/antifungal-agent-class-varies-by-specific-drug-azole-polyene-echinocandin-or-other.

What development phase is Antifungal treatment in?

Antifungal treatment is FDA-approved (marketed).

What are the side effects of Antifungal treatment?

Common side effects of Antifungal treatment include Hepatotoxicity, Nephrotoxicity, Infusion-related reactions, Gastrointestinal disturbances.

Related